Lantheus Medical Imaging

Lantheus develops, manufactures and commercializes essential diagnostic imaging agents and products that help healthcare professionals identify disease and improve patient treatment and care. Its pioneering products assist physicians in the diagnosis of conditions affecting the heart, brain, lungs and other organs using echocardiography, nuclear imaging and magnetic resonance imaging (MRI) technologies.
The Company's products are routinely used to diagnose coronary artery disease (CAD), congestive heart failure (CHF), stroke, peripheral vascular (PVD) and other diseases. In addition to Lantheus's diversified portfolio of commercialized imaging agents and products, it has a strong development pipeline of internally-discovered next generation, first-in-class imaging agents that use positron emission tomography (PET), MRI technologies focused on enhancing current imaging modalities and fulfilling unmet diagnostic medical imaging needs.

Billerica, US
Size (employees)
465 (est)-1%
Lantheus Medical Imaging was founded in 1956 and is headquartered in Billerica, US

Lantheus Medical Imaging Office Locations

Lantheus Medical Imaging has offices in Billerica, San Juan and Montréal
Billerica, US (HQ)
331 Treble Cove Rd
Montréal, CA
1111 Boulevard Dr. Frederik Philips, Suite 600
San Juan, PR
150 Calle Federico Acosta, Suite 1

Lantheus Medical Imaging Data and Metrics

Lantheus Medical Imaging Financial Metrics

Lantheus Medical Imaging's revenue was reported to be $301.9 m in FY, 2016 which is a 3% increase from the previous period.
$, USD

Revenue (FY, 2016)

301.9 m

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

137.8 m

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

26.8 m

EBIT (FY, 2016)

56.6 m

Market capitalization (23-Jun-2017)

581.3 m

Closing share price (23-Jun-2017)


Cash (31-Dec-2016)

51.2 m
Lantheus Medical Imaging's current market capitalization is $581.3 m.
$, USDFY, 2013FY, 2014FY, 2015FY, 2016


283.7 m301.6 m293.5 m301.9 m

Revenue growth, %


Cost of goods sold

206.3 m176.1 m157.9 m164.1 m

Gross profit

77.4 m125.5 m135.5 m137.8 m

Gross profit Margin, %


Sales and marketing expense

34.7 m36.5 m

R&D expense

14.4 m12.2 m

General and administrative expense

43.9 m38.8 m

Operating expense total

96.4 m83.7 m93 m87.6 m


(19 m)41.8 m42.5 m56.6 m

EBIT margin, %


Interest expense

42.9 m42.3 m(38.7 m)(26.6 m)

Interest income

104 k27 k24 k

Pre tax profit

(60.7 m)26 k(11.8 m)28.3 m

Income tax expense

1 m1.2 m3 m1.5 m

Net Income

(61.7 m)(1.2 m)(14.7 m)26.8 m
$, USDFY, 2013FY, 2014FY, 2015FY, 2016


16.7 m17.8 m28.6 m51.2 m

Accounts Receivable

38.9 m41.5 m13.7 m


18.3 m15.6 m17.2 m

Current Assets

77.3 m79.2 m90.1 m110.8 m


97.7 m96 m86.5 m


15.7 m15.7 m15.7 m15.7 m

Total Assets

259.4 m247.5 m242.4 m255.9 m

Accounts Payable

18.1 m15.7 m

Total Debt

11.7 m

Current Liabilities

55.6 m48.5 m35.7 m43.8 m

Common Stock

303 k367 k

Additional Paid-in Capital

2.9 m3.9 m175.6 m226.5 m

Retained Earnings

(238.3 m)(239.5 m)(359.2 m)(332.4 m)

Total Equity

(185.3 m)(106.5 m)

Debt to Equity Ratio

-0.1 x

Debt to Assets Ratio

0 x

Financial Leverage

-1.3 x-2.4 x
$, USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(61.7 m)(1.2 m)(14.7 m)26.8 m

Depreciation and Amortization

9.3 m9.9 m19.7 m18.3 m

Accounts Receivable

2.6 m(3.6 m)(2.5 m)


1 m(882 k)121 k

Accounts Payable

(1.1 m)(4 m)

Cash From Operating Activities

49.6 m

Capital Expenditures

(5 m)(8.1 m)(13.2 m)(7.4 m)

Cash From Investing Activities

3.3 m

Long-term Borrowings

(1.9 m)(78.7 m)

Cash From Financing Activities

(30.2 m)

Interest Paid

39.2 m39.2 m40.8 m24.4 m

Income Taxes Paid

187 k(112 k)

Free Cash Flow

42.2 m
$, USDY, 2016


636.8 k

Financial Leverage

-2.4 x

Lantheus Medical Imaging Market Value History

Lantheus Medical Imaging Company Life and Culture

You may also be interested in